Accumulating evidence shows that complement C3 is present in patients of all major neurodegenerative diseases, including Parkinson’s disease, Alzheimer’s disease, Huntington’s disease, and amyotrophic lateral sclerosis [6-9]. The gene discussed is C3; the disease is early-onset autosomal dominant Alzheimer disease.